Lv3
222 积分 2022-06-21 加入
An update on IL-22 therapies in alcohol-associated liver disease and beyond
2小时前
已完结
Coordinated action of a gut–liver pathway drives alcohol detoxification and consumption
22天前
已完结
Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets
3个月前
已完结
Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease
3个月前
已完结
Defining Organ Failures in Patients with Cirrhosis: Consensus Statements
4个月前
已关闭
Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets
4个月前
已完结
Simvastatin and Rifaximin in Decompensated Cirrhosis
5个月前
已完结
Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multi-Centric Study
8个月前
已完结
The Immunomodulatory Potential of the Metabolite Itaconate
8个月前
已完结
ACOD1 in immunometabolism and disease
8个月前
已完结
皖公网安备34019202002308
